Why is Remedium Life falling/rising?

As of 28-Aug, Remedium Lifecare Ltd's stock price is currently at 1.25, reflecting a decline of 0.03 or 2.34%. The stock has underperformed its sector by 1.3% today and has experienced a consecutive fall over the last two days, resulting in a total drop of 6.02%. The stock's performance over the past week shows a decrease of 4.58%, while it has fallen by 65.03% year-to-date and 82.78% over the past year. The company has reported negative results for the last four consecutive quarters, with a significant decline in net sales by 76.36%. Additionally, the high Debt to EBITDA ratio of -1.00 times indicates a low ability to service debt, contributing to the stock's negative sentiment among investors. In the broader market context, the Sensex has declined by 2.34% over the past week, indicating that the stock's short-term performance is worse than the benchmark. While the stock has shown some resilience over a three-year period with a return of 50.19%, its long-term growth prospects appear poor, as evidenced by an annual operating profit decline of 303.30% over the last five years. The stock's liquidity is adequate for trading, but falling investor participation, with a delivery volume decrease of 62.64% against the five-day average, suggests waning interest. Overall, the combination of poor financial performance, high debt levels, and negative market sentiment has led to the stock's continued decline.